Skip Navigation
Skip to contents
Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

16 results
Display

P53 expression in hepatocellular carcinoma: influence on the radiotherapeutic response of the hepatocellular carcinoma

Lee YR, Park SY

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Managing alcoholic liver disease

Shah VH

Alcoholic liver disease continues to be a significant cause of liver-related morbidity and mortality throughout the world. A number of diagnostic and prognostic models have been developed in the management...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Sarcomatoid cholangiocarcinoma with osteoclast-like giant cells associated with hepatolithiasis: A case report

Kim HM, Kim H, Park YN

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Portal flow steal after liver transplantation

Kim B, Kim KW, Song GW, Lee SG

Portal flow steal occasionally persists even after the liver transplantation, which may reduce the portal flow and thus threaten the patients' outcome. Therefore, pre- and peri-operative detection of portal steal...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Long-term outcomes of patients with advanced hepatocellular carcinoma who achieved complete remission after sorafenib therapy

Park JG

BACKGROUND/AIMS: Sorafenib is currently the sole molecular targeted agent that improves overall survival in advanced hepatocellular carcinoma (HCC). Despite the efficacy of sorafenib, the response rate varies in patients with...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Personalized management of cirrhosis by non-invasive tests of liver fibrosis

Wong GL, Espinosa W, Wong VW

Owing to the high prevalence of various chronic liver diseases, cirrhosis is one of the leading causes of morbidity and mortality worldwide. In recent years, the development of non-invasive tests...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Imaging findings for intravascular large B-cell lymphoma of the liver

Bae J, Lim HK, Park HY

Intravascular large B-cell lymphoma (IVLBCL) is a rare subtype of extranodal diffuse large B-cell lymphoma that most commonly involves the central nervous system and skin. To our knowledge, no state-of-the...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Entecavir plus tenofovir versus entecavir plus adefovir in chronic hepatitis B patients with a suboptimal response to lamivudine and adefovir combination therapy

Park JG, Park SY

BACKGROUND/AIMS: We compared the efficacies of entecavir (ETV) plus tenofovir (TDF) and ETV plus adefovir (ADV) in chronic hepatitis B (CHB) patients with genotypic resistance to lamivudine (LAM) who showed...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The mutational landscape of hepatocellular carcinoma

Lee JS

The development of hepatocellular carcinoma (HCC) is a complex process, and HCC arises from the accumulation of multiple genetic alterations leading to changes in the genomic landscape. Current advances in...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Preference elicitation approach for measuring the willingness to pay for liver cancer treatment in Korea

Cho D, Jo C

BACKGROUND/AIMS: The Korean government has expanded the coverage of the national insurance scheme for four major diseases: cancers, cardiovascular diseases, cerebrovascular diseases, and rare diseases. This policy may have a...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
From DCPD to NTCP: The long journey towards identifying a functional hepatitis B virus receptor

Li J, Tong S

Hepatitis B virus (HBV) is the prototype of hepatotropic DNA viruses (hepadnaviruses) infecting a wide range of human and non-human hosts. Previous studies with duck hepatitis B virus (DHBV) identified...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Influence of P53 on the radiotherapy response of hepatocellular carcinoma

Gomes AR, Abrantes A, Brito AF, Laranjo M, Casalta-Lopes JE, Goncalves , Sarmento-Ribeiro AB, Botelho MF, Tralhao JG

BACKGROUND/AIMS: Hepatocellular carcinoma (HCC) is one of the most common cancers worldwide, and it has a poor prognosis and few therapeutic options. Radiotherapy is one of the most effective forms...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A case of hepatoblastoma misdiagnosed as combined hepatocellular carcinoma and cholangiocarcinoma in an adult

Park KW, Seo CJ, Yun DY, Kim MK, Kim BS, Han YS, Oh HK, Lee CH

Hepatoblastoma usually occurs in children under the age of 2 years, with very few cases reported in adults. We experienced a case of adult hepatoblastoma in a 36-year-old female with...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Growth rate of early-stage hepatocellular carcinoma in patients with chronic liver disease

An C, Choi YA, Choi D, Paik YH, Ahn SH, Kim MJ, Paik SW, Han KH, Park MS

BACKGROUND/AIMS: The goal of this study was to estimate the growth rate of hepatocellular carcinoma (HCC) and identify the host factors that significantly affect this rate. METHODS: Patients with early-stage HCC...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Static and dynamic prognostic factors for hepatitis-B-related acute-on-chronic liver failure

Ha JM, Sohn W, Cho JY, Pyo JH, Choi K, Sinn DH, Gwak GY, Choi MS, Lee JH, Koh KC, Paik SW, Yoo BC, Paik YH

BACKGROUND/AIMS: Hepatitis-B-related acute-on-chronic liver failure has a poor prognosis. However, the advent of potent oral antiviral agents means that some patients can now recover with medical treatment. We aimed to...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Comparison and analysis of the prevalence of hepatitis C virus infection by region in the Republic of Korea during 2005-2012

Shon HS, Choi HY, Kim JR, Ryu SY, Lee YJ, Lee MJ, Min HJ, Lee J, Song YJ, Ki M

BACKGROUND/AIMS: This study compared the prevalence of hepatitis C virus (HCV) infection in the Republic of Korea and estimated the high-risk regions and towns. METHODS: National Health Insurance Service data for...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr